Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Adam Kittai is a hematologist who specializes in the treatment of chronic lymphocytic leukemia (CLL) and Richter’s syndrome. He is passionate about guiding every one of my patients through their treatment process, personalizing care to each patient’s individual needs. Furthermore, he enjoys developing novel therapies and optimizing regimens that we currently utilize at the OSUCCC – James.
As a member of The James team, Dr. Kittai has the opportunity to work with cutting-edge technologies and the ability to enroll patients in important clinical trials. It’s exciting to have access to these tools because they allow him to provide the best care to my patients. In the CLL group, he specifically has an interest in developing targeted and cellular therapies to treat this disease. He also works closely with the basic science labs to translate medical advances rapidly from bench to bedside.
He is an assistant professor in the Division of Hematology at The Ohio State University, where he has the opportunity to work with students and help them understand the treatment of CLL and other hematologic malignancies, as well as the unique relationship that can be fostered between patient and physician. He is also a member of various professional organizations, including the American Society of Hematology, the American Society of Clinical Oncology and the American Association for Cancer Research.